Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,104 public trials 1,784 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Active, not recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

NCT06298552

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +13 more
Locations
  • HonorHealth Neurology - Bob Bove Neuroscience Institute Scottsdale, Arizona, United States
  • Loma Linda University Health Fresno, California, United States
  • First Choice Neurology Boca Raton Boca Raton, Florida, United States
  • SFM Clinical Research LLC Boca Raton, Florida, United States
View all 91 locations
View Trial Details
Active, not recruiting

Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)

NCT02461459

Conditions
Autism Disorder, Autism Spectrum Disorder, Autistic Disorder, +23 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California at Los Angeles Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Adult Spinal Muscular Atrophy (SMA) China Registry

NCT05618379

Conditions
Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +4 more
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China
  • The First Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
  • Peking University Shenzhen Hospital Shenzhen, Guangdong, China
View Trial Details
Active, not recruiting

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

NCT06220201

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +13 more
Locations
  • Local Institution - 0011 Birmingham, Alabama, United States
  • University of California, Irvine Irvine, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 34 locations
View Trial Details

Related conditions